Media-OutReach Newswire ZENCE OBJECT Announces Additional RMB10 Million Investment, Forms Strategic Partnership to Accelerate Green Technology Expansion
Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment 2.